Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMVT Immunovant, Inc.

交易中 04-15 15:17:19 EDT

27.30

+0.75

+2.82%

最高27.63	最低26.49	成交量110.12万
今开26.89	昨收26.55	日振幅4.29%
总市值55.56亿	流通市值24.30亿	总股本2.04亿
成交额2,984万	换手率1.24%	流通股本8,902万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMVT","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":27.3,"timestamp":1776280631439,"preClose":26.55,"halted":0,"volume":1101156,"delay":0,"changeRate":0.02824858757062147,"floatShares":89017500,"shares":203532180,"eps":-2.679914,"marketStatus":"交易中","change":0.75,"latestTime":"04-15 15:17:19 EDT","open":26.885,"high":27.63,"low":26.49,"amount":29841404.680919997,"amplitude":0.042938,"askPrice":27.32,"askSize":205,"bidPrice":27.28,"bidSize":632,"shortable":3,"etf":0,"ttmEps":-2.679914,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1776283200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":26.55,"preHourTrading":{"tag":"盘前","latestPrice":26.99,"preClose":26.55,"latestTime":"09:25 EDT","volume":1683,"amount":45260.474688,"timestamp":1776259500026,"change":0.44,"changeRate":0.016573,"amplitude":0.031951},"postHourTrading":{"tag":"盘后","latestPrice":26.55,"preClose":26.55,"latestTime":"19:22 EDT","volume":34157,"amount":906867.9,"timestamp":1776208963388,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.822119,"impliedVol":0.4537,"impliedVolPercentile":0.332},"requestUrl":"/m/hq/s/IMVT","defaultTab":"news","newsList":[{"id":"1115169106","title":"异动解读 | Immunovant发布第三季度财务业绩，盘中大涨11.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115169106","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115169106?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:56","pubTimestamp":1770389766,"startTime":"0","endTime":"0","summary":"Immunovant, Inc.(IMVT)今日盘中大涨11.72%，引起了市场的广泛关注。消息面上，Immunovant, Inc.于今日盘前正式发布了截至2025年12月31日的第三季度财务报告，同时披露了公司在业务运营方面的关键进展。这份财务业绩的公布，为投资者提供了评估公司近期表现和未来前景的重要依据，可能是推动股价上涨的主要因素。该公司此次公布的第三季度财务报告涵盖了详尽的财务数据和业务更新，这些信息通常会对市场情绪产生显著影响，并直接反映在股价变动上。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177445822","title":"Immunovant公布企业最新进展及2025年12月31日截止第三季度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1177445822","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177445822?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:01","pubTimestamp":1770379308,"startTime":"0","endTime":"0","summary":"Immunovant, Inc.近日披露了公司最新动态，并正式发布了截至2025年12月31日的第三季度财务报告。此次公告涵盖了公司在业务运营方面的关键更新以及详尽的财务数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4139","IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584640929","title":"Immunovant, Inc.2025财年第三财季实现净利润-1.27亿美元，同比减少16.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584640929","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584640929?lang=zh_cn&edition=full","pubTime":"2025-11-17 00:01","pubTimestamp":1763308861,"startTime":"0","endTime":"0","summary":"11月17日，Immunovant, Inc.公布财报，公告显示公司2025财年第三财季净利润为-1.27亿美元，同比减少16.51%；其中营业收入为0.00美元，每股基本收益为-0.73美元。从资产负债表来看，Immunovant, Inc.总负债63.25百万美元，其中短期债务0.00美元，资产负债比为0.10，流动比率为0.10。机构评级：截至2025年11月17日，当前有15家机构对Immunovant, Inc.目标价做出预测，其中目标均价为38.73美元，其中最低目标价为16.00美元，最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000121a4a5a940&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000121a4a5a940&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","IMVTW","IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583766535","title":"Immunovant, Inc.盘中异动 早盘股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583766535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583766535?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:44","pubTimestamp":1762958667,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时44分，Immunovant, Inc.股票出现异动，股价大幅拉升5.29%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Immunovant, Inc.公司简介：Immunovant Inc是一家临床阶段的免疫学公司，致力于帮助自身免疫性疾病患者恢复正常生活。消息层面，截至22时44分，《H.C. Wainwright维持Immunovant买入评级，维持目标价35美元》资讯为影响Immunovant, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112224428a6f4b9a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112224428a6f4b9a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTW","IMVT","BK4139","IMVTU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582535542","title":"Immunovant, Inc.盘中异动 早盘股价大跌5.22%报22.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582535542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582535542?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:39","pubTimestamp":1762785542,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分，Immunovant, Inc.股票出现异动，股价急速下挫5.22%。截至发稿，该股报22.13美元/股，成交量10.5238万股，换手率0.06%，振幅6.47%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Immunovant, Inc.公司简介：Immunovant Inc是一家临床阶段的免疫学公司，致力于帮助自身免疫性疾病患者恢复正常生活。消息层面，截至22时39分，《H.C. Wainwright维持Immunovant买入评级，维持目标价35美元》资讯为影响Immunovant, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022390294fb9618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022390294fb9618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","BK4588","BK4139","BK4585","IMVTU","IMVTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169489350","title":"Immunovant, Inc.：公司预计将在2026年上半年同时分享两个Ted研究的主要结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1169489350","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169489350?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:06","pubTimestamp":1762776379,"startTime":"0","endTime":"0","summary":"Immunovant, Inc.：公司预计将在2026年上半年同时分享两个Ted研究的主要结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4585","IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119457388","title":"Immunovant, Inc.：有望在2025年年末前公布首个Bataclimab三期Ted研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1119457388","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119457388?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:04","pubTimestamp":1762776251,"startTime":"0","endTime":"0","summary":"Immunovant, Inc.：有望在2025年年末前公布首个Bataclimab三期Ted研究结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","IMVT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196642944","title":"Immunovant发布公司最新动态并公布2025年9月30日第二季度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1196642944","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196642944?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:01","pubTimestamp":1762776073,"startTime":"0","endTime":"0","summary":"Immunovant发布公司最新动态并公布2025年9月30日第二季度财务业绩","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT","BK4139","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577892294","title":"Immunovant, Inc.盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577892294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577892294?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:38","pubTimestamp":1760967487,"startTime":"0","endTime":"0","summary":"北京时间2025年10月20日21时38分，Immunovant, Inc.股票出现异动，股价急速上涨5.20%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Replimune Group, Inc.、Celcuity Inc.、Azitra Inc涨幅较大，Azitra Inc、Genprex, Inc.、Scisparc Ltd.较为活跃，换手率分别为1082.29%、343.18%、112.33%，振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Rapt Therapeutics, Inc.、Replimune Group, Inc.，振幅分别为30.27%、29.52%、18.44%。Immunovant, Inc.公司简介：Immunovant Inc是一家临床阶段的免疫学公司，致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102021380794d3f2f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102021380794d3f2f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","IMVT","BK4588","BK4585","IMVTW","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518277747","title":"Guggenheim：重申Immunovant(IMVT.US)评级，由买入调整至买入评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277747","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277747?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:25","pubTimestamp":1741623919,"startTime":"0","endTime":"0","summary":"Guggenheim：重申Immunovant(IMVT.US)评级，由买入调整至买入评级。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11002548640656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517923782","title":"Immunovant, Inc.盘中异动 下午盘急速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517923782?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:09","pubTimestamp":1741201780,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时09分，Immunovant, Inc.股票出现异动，股价急速上涨5.03%。截至发稿，该股报19.42美元/股，成交量41.073万股，换手率0.24%，振幅4.16%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为2.04%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为957.19%、307.92%、304.87%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.，振幅分别为82.59%、54.27%、50.73%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030940a26114f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030940a26114f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","BK4139","BK4588","BK4585","IMVTU","IMVTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634234","title":"Immunovant, Inc.盘中异动 股价大跌5.07%报19.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634234?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:37","pubTimestamp":1741012660,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时37分，Immunovant, Inc.股票出现异动，股价快速跳水5.07%。截至发稿，该股报19.56美元/股，成交量5.6534万股，换手率0.03%，振幅4.61%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Geovax Labs, Inc.、Alto Neuroscience, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.52%、33.60%、31.61%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为21.22%、19.25%、18.04%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223740abe6353f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223740abe6353f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMVTU","IMVT","BK4585","BK4588","IMVTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513299488","title":"Immunovant, Inc.盘中异动 股价大涨5.04%报21.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513299488?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:47","pubTimestamp":1740149263,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时47分，Immunovant, Inc.股票出现波动，股价快速上涨5.04%。截至发稿，该股报21.48美元/股，成交量6.2287万股，换手率0.04%，振幅3.33%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为82.80%、82.33%、30.61%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为46.92%、35.45%、33.83%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224743a24eb474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224743a24eb474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","IMVTW","IMVT","BK4585","IMVTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165963","title":"Immunovant, Inc.盘中异动 快速拉升5.02%报21.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165963?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:43","pubTimestamp":1739889809,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时43分，Immunovant, Inc.股票出现波动，股价大幅上涨5.02%。截至发稿，该股报21.35美元/股，成交量3.9537万股，换手率0.02%，振幅4.06%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为303.62%、108.85%、87.42%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224329abd3b1ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224329abd3b1ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","BK4139","BK4585","BK4588","IMVTW","IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510896480","title":"Immunovant, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510896480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510896480?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:29","pubTimestamp":1739212142,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时29分，Immunovant, Inc.股票出现异动，股价大幅下挫5.24%。截至发稿，该股报19.34美元/股，成交量134.362万股，换手率0.79%，振幅8.43%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Dominari Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3063.98%、1638.48%、1333.54%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Biodexa Pharmaceuticals Plc，振幅分别为99.86%、87.80%、87.71%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211022903a240d2f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211022903a240d2f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","IMVTW","IMVT","BK4588","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510850397","title":"Guggenheim：维持Immunovant(IMVT.US)评级，由买入调整至买入评级, 目标价由46.00美元调整至44.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510850397","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510850397?lang=zh_cn&edition=full","pubTime":"2025-02-10 21:52","pubTimestamp":1739195541,"startTime":"0","endTime":"0","summary":"Guggenheim：维持Immunovant(IMVT.US)评级，由买入调整至买入评级, 目标价由46.00美元调整至44.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/10215248063272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159397865","title":"Immunovant 2025年第三季度GAAP每股收益$(0.76)，符合预期，截止2024年12月31日的备考现金余额约为8.25亿美元，包括约4.5亿美元的私人配售总收益","url":"https://stock-news.laohu8.com/highlight/detail?id=1159397865","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159397865?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:42","pubTimestamp":1738842172,"startTime":"0","endTime":"0","summary":"Immunovant 报告季度每股亏损$，符合分析师预期。这比去年同期每股亏损$增加了111.11%。以上内容来自Benzinga Earnings专栏，原文如下：Immunovant  reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 111.11 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Immunovant 2025年第三季度GAAP每股收益$(0.76)，符合预期，截止2024年12月31日的备考现金余额约为8.25亿美元，包括约4.5亿美元的私人配售总收益","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508828142","title":"Immunovant, Inc.盘中异动 大幅下跌5.15%报20.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508828142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508828142?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:07","pubTimestamp":1738595249,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时07分，Immunovant, Inc.股票出现波动，股价急速跳水5.15%。截至发稿，该股报20.62美元/股，成交量14.1163万股，换手率0.08%，振幅3.31%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，Hcw Biologics Inc.、Invivyd, Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为500.44%、395.41%、260.41%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为136.56%、71.79%、50.76%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230729a238117a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230729a238117a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","IMVTU","BK4588","IMVTW","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500112349","title":"Wolfe Research：下调Immunovant(IMVT.US)评级，由优于大市调整至Peer Perform评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500112349","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500112349?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:52","pubTimestamp":1735915948,"startTime":"0","endTime":"0","summary":"Wolfe Research：下调Immunovant(IMVT.US)评级，由优于大市调整至Peer Perform评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/03225247115140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492380177","title":"富国银行：维持Immunovant评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492380177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492380177?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:08","pubTimestamp":1734620887,"startTime":"0","endTime":"0","summary":"富国银行：维持immunovant(IMVT.US)评级，由增持调整至增持评级,目标价由47.00美元调整至45.00美元。Immunovant(IMVT.US)公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。它致力于让自身免疫性疾病患者能够正常生活。该公司的产品包括batoclimab和针对新生儿Fc受体(FcRn)的IMVT-1402。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219231501a1fb6b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219231501a1fb6b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunovant.com","stockEarnings":[{"period":"1week","weight":0.0788},{"period":"1month","weight":0.0877},{"period":"3month","weight":-0.0293},{"period":"6month","weight":0.525},{"period":"1year","weight":0.7207},{"period":"ytd","weight":0.0445}],"compareEarnings":[{"period":"1week","weight":0.0535},{"period":"1month","weight":0.0486},{"period":"3month","weight":0.0059},{"period":"6month","weight":0.0512},{"period":"1year","weight":0.2881},{"period":"ytd","weight":0.0184}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunovant, Inc.于2018年12月6日在特拉华州注册成立,是一家临床阶段生物制药公司，专注于为自身免疫性疾病患者提供正常生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.081969},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.118937},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.068553},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.012805},{"month":5,"riseRate":0.333333,"avgChangeRate":0.069275},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.068981},{"month":7,"riseRate":0.571429,"avgChangeRate":0.040449},{"month":8,"riseRate":0.571429,"avgChangeRate":0.080342},{"month":9,"riseRate":0.857143,"avgChangeRate":0.12082},{"month":10,"riseRate":0.714286,"avgChangeRate":0.22916},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058678},{"month":12,"riseRate":0.714286,"avgChangeRate":0.132246}],"exchange":"NASDAQ","name":"Immunovant, Inc.","nameEN":"Immunovant, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunovant, Inc.,IMVT,Immunovant, Inc.股票,Immunovant, Inc.股票老虎,Immunovant, Inc.股票老虎国际,Immunovant, Inc.行情,Immunovant, Inc.股票行情,Immunovant, Inc.股价,Immunovant, Inc.股市,Immunovant, Inc.股票价格,Immunovant, Inc.股票交易,Immunovant, Inc.股票购买,Immunovant, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}